CANO RSI Chart
Last 7 days
4.6%
Last 30 days
-14.8%
Last 90 days
-94.2%
Trailing 12 Months
-81.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.9B | 3.0B | 3.1B | 3.1B |
2022 | 2.0B | 2.4B | 2.6B | 2.7B |
2021 | 970.9M | 1.1B | 1.4B | 1.6B |
2020 | 0 | 518.1M | 674.8M | 831.6M |
2019 | 0 | 0 | 0 | 361.4M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 01, 2024 | cooperstone elliot | sold | -2,780 | 2.5277 | -1,100 | - |
Jan 31, 2024 | cooperstone elliot | sold | -23,177 | 2.594 | -8,935 | - |
Jan 30, 2024 | cooperstone elliot | sold | -34,285 | 2.699 | -12,703 | - |
Jan 29, 2024 | cooperstone elliot | sold | -113,471 | 2.7437 | -41,357 | - |
Jan 26, 2024 | cooperstone elliot | sold | -89,735 | 2.7448 | -32,693 | - |
Jan 25, 2024 | cooperstone elliot | sold | -47,960 | 2.5828 | -18,569 | - |
Jan 24, 2024 | cooperstone elliot | sold | -101,612 | 2.8377 | -35,808 | - |
Jan 23, 2024 | cooperstone elliot | sold | -214,800 | 2.9411 | -73,034 | - |
Jan 22, 2024 | cooperstone elliot | sold | -312,762 | 2.5021 | -125,000 | - |
Jan 18, 2024 | cooperstone elliot | sold | -191,250 | 1.9125 | -100,000 | - |
Which funds bought or sold CANO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 18, 2024 | Capital Advisors, Ltd. LLC | sold off | -100 | - | - | -% |
Apr 18, 2024 | Allspring Global Investments Holdings, LLC | sold off | -100 | -5,036 | - | -% |
Apr 16, 2024 | Arlington Trust Co LLC | sold off | -100 | -23.00 | - | -% |
Apr 09, 2024 | MASSMUTUAL TRUST CO FSB/ADV | unchanged | - | -565 | 22.00 | -% |
Apr 05, 2024 | CWM, LLC | unchanged | - | - | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | sold off | -100 | -4,708,890 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | new | - | 734,467 | 734,467 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | sold off | -100 | -104,774 | - | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | sold off | -100 | -31,927 | - | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | new | - | 7,608 | 7,608 | -% |
Unveiling Cano Health, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Cano Health, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 448.5B | 371.6B | 20.04 | 1.21 | ||||
CI | 103.1B | 195.3B | 19.19 | 0.53 | ||||
CVS | 86.2B | 357.8B | 10.32 | 0.24 | ||||
HCA | 84.5B | 65.0B | 16.12 | 1.3 | ||||
CNC | 40.6B | 154.0B | 15.01 | 0.26 | ||||
DVA | 11.7B | 12.1B | 16.99 | 0.97 | ||||
UHS | 11.4B | 14.3B | 15.93 | 0.8 | ||||
MID-CAP | ||||||||
CHE | 9.3B | 2.3B | 34.2 | 4.12 | ||||
ACHC | 6.5B | 2.9B | -301.31 | 2.23 | ||||
AMN | 2.2B | 3.8B | 10.28 | 0.57 | ||||
AMEH | 2.1B | 1.4B | 34.21 | 1.5 | ||||
SMALL-CAP | ||||||||
ADUS | 1.5B | 1.1B | 24.6 | 1.45 | ||||
BKD | 1.3B | 3.0B | -6.94 | 0.44 | ||||
BEAT | 53.7M | - | -3.67 | - | ||||
AMS | 19.0M | 21.3M | 35.63 | 0.89 |
Cano Health, Inc. News
Income Statement (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Revenue | -9.1% | 716,028,500 | 788,073,000 | 766,746,000 | 866,909,000 | 680,275,500 | 665,028,000 | 689,373,000 | 704,337,000 | 492,255,000 | 498,931,000 | 343,581,000 | 274,602,000 | 261,939,000 | 263,133,000 | 171,206,000 | - |
Operating Expenses | -22.8% | 968,374,500 | 1,254,992,000 | 1,012,380,000 | 906,438,000 | 71,652,000 | 696,473,000 | 720,422,000 | 715,793,000 | 534,512,000 | 532,523,000 | 398,145,000 | 279,377,000 | 332,221,294 | 256,520,000 | 176,117,000 | - |
S&GA Expenses | 6.5% | 86,098,000 | 80,821,000 | 99,418,000 | 96,473,000 | 2,122,000 | 111,765,000 | 106,179,000 | 96,587,000 | 93,347,000 | 76,618,000 | 47,159,000 | 35,009,000 | 33,728,000 | 27,391,000 | 21,859,000 | - |
EBITDA Margin | 7.9% | -0.28 | -0.30 | -0.19 | -0.12 | -0.11 | 0.01 | 0.02 | 0.01 | -0.01 | -0.06 | -0.04 | -0.02 | -0.02 | 0.00 | -0.01 | -0.01 |
Interest Expenses | 17.6% | 34,867,500 | 29,646,000 | 26,719,000 | 23,500,000 | 19,623,500 | 16,451,000 | 13,134,000 | 13,300,000 | 14,938,500 | 16,023,000 | 9,700,000 | 10,600,000 | 12,274,000 | 12,346,000 | 5,717,000 | - |
Income Taxes | 233.4% | 193,500 | -145,000 | -1,872,000 | - | 1,516,000 | -1,248,000 | 809,000 | 1,080,000 | 776,000 | 547,000 | -2,023,000 | 714,000 | 357,000 | 326,000 | -19,000 | - |
Earnings Before Taxes | 44.0% | -275,674,000 | -491,842,000 | -272,617,000 | -60,585,000 | -300,213,000 | -113,259,000 | -13,755,000 | 995,000 | 1,280,500 | -64,293,000 | -38,312,000 | -15,400,000 | -46,418,000 | -10,791,000 | -11,005,000 | - |
EBT Margin | 3.3% | -0.35 | -0.36 | -0.25 | -0.17 | -0.16 | -0.05 | -0.03 | -0.05 | -0.07 | -0.12 | -0.10 | -0.09 | -0.08 | -0.03 | -0.04 | -0.05 |
Net Income | 36.6% | -165,028,000 | -260,487,000 | -140,753,000 | -28,150,000 | 299,000 | -54,228,000 | -5,333,000 | 660,000 | 8,719,000 | -23,238,000 | 4,555,000 | -16,114,000 | -47,866,293 | -11,117,000 | -10,986,000 | - |
Net Income Margin | -37.0% | -0.19 | -0.14 | -0.07 | -0.03 | -0.02 | -0.02 | -0.01 | 0.00 | -0.02 | -0.06 | -0.06 | -0.09 | -0.08 | -0.03 | -0.04 | -0.05 |
Free Cashflow | 2.5% | -45,443,000 | -46,614,000 | -21,675,000 | -34,550,000 | -72,647,000 | -20,615,000 | -57,625,000 | -44,979,000 | -34,673,000 | -51,884,000 | -48,497,000 | -17,333,000 | 9,178,000 | -13,371,000 | - | - |
Balance Sheet | ||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 |
Assets | -16.4% | 1,014 | 1,212 | 1,707 | 1,944 | 1,929 | 2,196 | 2,141 | 2,172 | 2,144 | 2,140 | 1,659 | 691 | 614 | 692 | 693 | - | - |
Current Assets | 26.3% | 183 | 145 | 166 | 314 | 341 | 305 | 287 | 324 | 317 | 465 | 472 | 1.00 | 111 | 2.00 | 2.00 | - | - |
Cash Equivalents | 83.4% | 76.00 | 41.00 | 28.00 | 45.00 | 27.00 | 24.00 | 48.00 | 113 | 163 | 209 | 319 | 7.00 | 34.00 | 27.00 | 11.00 | - | 29.00 |
Inventory | - | - | - | - | - | - | - | - | - | 1.00 | 2.00 | 1.00 | - | 1.00 | - | - | - | - |
Net PPE | - | - | - | - | - | - | 126 | 106 | 96.00 | 85.00 | 64.00 | 46.00 | - | 38.00 | - | - | - | - |
Goodwill | -100.0% | - | 89.00 | 480 | 480 | 480 | 788 | 777 | 773 | 770 | 766 | 151 | - | 234 | 90.00 | 90.00 | - | 14.00 |
Liabilities | 5.3% | 1,549 | 1,471 | 1,472 | 1,440 | 1,435 | 1,413 | 1,300 | 1,334 | 1,345 | 1,282 | 771 | 134 | 565 | 24.00 | 24.00 | - | - |
Current Liabilities | 286.8% | 1,415 | 366 | 337 | 214 | 208 | 186 | 142 | 159 | 161 | 140 | 93.00 | 3.00 | 67.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Shareholder's Equity | -Infinity% | -535 | - | 236 | 504 | 253 | 783 | 841 | 838 | 799 | 780 | 834 | 34.00 | 50.00 | 207 | 224 | 111 | 87.00 |
Retained Earnings | -23.1% | -880 | -715 | -454 | -314 | -286 | -137 | -83.43 | -78.10 | -78.76 | -52.55 | -37.64 | -47.02 | -107 | -7.11 | -2.57 | -0.01 | -0.01 |
Additional Paid-In Capital | -10.3% | 532 | 593 | 602 | 595 | 539 | 544 | 496 | 464 | 397 | 363 | 390 | 52.00 | - | 12.00 | 8.00 | 0.00 | - |
Shares Outstanding | -100.0% | - | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | - | 0.00 | - |
Minority Interest | -36.5% | -187 | -137 | 89.00 | 224 | 242 | 377 | 429 | 452 | 480 | 547 | 536 | - | - | - | - | - | - |
Cashflow (Quarterly) | |||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2019Q4 |
Cashflow From Operations | -11.6% | -44.35 | -39.74 | -15.48 | -29.47 | -62.18 | -1.98 | -44.97 | -37.20 | -23.54 | -36.39 | -43.41 | -14.69 | 12.00 | -7.90 | - | - |
Share Based Compensation | 121.9% | 1.00 | -4.08 | 2.00 | 9.00 | 12.00 | 11.00 | 18.00 | 14.00 | 15.00 | 9.00 | 4.00 | 0.00 | 0.00 | 0.00 | - | - |
Cashflow From Investing | -92.0% | 2.00 | 27.00 | -8.24 | -9.46 | -16.00 | -18.88 | -15.82 | -13.46 | -18.40 | -466 | -636 | -9.70 | -14.81 | -7.63 | - | - |
Cashflow From Financing | 186.5% | 77.00 | 27.00 | 7.00 | 56.00 | 81.00 | -2.88 | -4.42 | 1.00 | -3.80 | 393 | 992 | -2.82 | 9.00 | 32.00 | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 12 Months Ended | ||||
---|---|---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |||
Revenue: | |||||
Total revenue | $ 3,137,757 | $ 2,738,916 | $ 1,609,369 | ||
Operating expenses: | |||||
Third-party medical costs | 2,830,421 | 2,062,356 | 1,231,047 | ||
Direct patient expense (Related parties comprised $10,592, $9,683 and $4,882 in the years ended December 31, 2023, 2022 and 2021, respectively) | 228,057 | 254,867 | 179,353 | ||
Selling, general, and administrative expenses (Related parties comprised $6,417, $9,230 and $12,366 in the years ended December 31, 2023, 2022 and 2021, respectively) | 362,810 | 422,443 | 252,133 | ||
Depreciation and amortization expense (excluding accelerated amounts) | 106,080 | 90,640 | 49,441 | ||
Accelerated depreciation and amortization for property and equipment, and right-of-use assets | 80,560 | 0 | 0 | ||
Transaction costs | 32,139 | 27,435 | 44,262 | ||
Change in fair value of contingent consideration | (2,800) | (5,025) | (11,680) | ||
Goodwill impairment loss | 442,918 | 323,000 | 0 | ||
Credit loss on other assets | 62,000 | 0 | 0 | ||
Total operating expenses | 4,142,185 | 3,175,716 | 1,744,556 | ||
Income (loss) from operations | (1,004,428) | (436,800) | (135,187) | ||
Other income (expense): | |||||
Interest expense | (114,750) | (62,495) | (51,291) | ||
Interest income | 572 | 14 | 4 | ||
Loss on extinguishment of debt | 0 | (1,428) | (13,115) | ||
Change in fair value of warrant liabilities | 7,373 | 72,771 | 82,914 | ||
Other income (expense) | 10,515 | 1,706 | (48) | ||
Total other income (expense) | (96,290) | 10,568 | 18,464 | ||
Net income (loss) before income tax expense | (1,100,718) | (426,232) | (116,723) | ||
Income tax expense (benefit) | (1,815) | 2,157 | 14 | ||
Net income (loss) | (1,098,903) | (428,389) | (116,737) | ||
Net income (loss) attributable to non-controlling interests | (504,485) | (221,117) | (98,717) | ||
Net income (loss) attributable to Class A common stockholders | $ (594,418) | $ (207,272) | $ (18,020) | ||
Net income (loss) per share attributable to Class A common stockholders, basic (in dollars per share) | $ (215.83) | $ (94.57) | $ (10.57) | ||
Net income (loss) per share attributable to Class A common stockholders, diluted (in dollars per share) | $ (242.60) | $ (94.57) | $ (28.28) | ||
Weighted-average shares outstanding | |||||
Basic (in shares) | [1] | 2,754,116 | 2,191,669 | 1,705,072 | |
Diluted (in shares) | [1] | 4,529,622 | 2,191,669 | 4,756,972 | |
Related Party | |||||
Operating expenses: | |||||
Direct patient expense (Related parties comprised $10,592, $9,683 and $4,882 in the years ended December 31, 2023, 2022 and 2021, respectively) | $ 10,592 | $ 9,683 | $ 4,882 | ||
Selling, general, and administrative expenses (Related parties comprised $6,417, $9,230 and $12,366 in the years ended December 31, 2023, 2022 and 2021, respectively) | 6,417 | 9,230 | 12,366 | ||
Capitated revenue | |||||
Revenue: | |||||
Total revenue | 3,054,412 | 2,606,916 | 1,529,120 | ||
Fee-for-service and other revenue | |||||
Revenue: | |||||
Total revenue | $ 83,345 | $ 132,000 | $ 80,249 | ||
|
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
Current assets: | ||||
Cash, cash equivalents and restricted cash | $ 75,763 | $ 27,329 | ||
Accounts receivable, net of unpaid service provider costs | 75,801 | 233,816 | ||
Equity securities at fair value | 18,160 | 0 | ||
Prepaid expenses and other current assets | 13,099 | 79,603 | ||
Total current assets | 182,823 | 340,748 | ||
Property and equipment, net | 54,641 | 131,325 | ||
Operating lease right-of-use assets | 78,458 | 177,892 | ||
Goodwill | 0 | 480,375 | ||
Payor relationships, net | 525,511 | 567,704 | ||
Other intangibles, net | 167,453 | 226,059 | ||
Other assets | 4,853 | 4,824 | ||
Total assets | 1,013,739 | 1,928,927 | ||
Current liabilities: | ||||
Accounts payable and accrued expenses (Related parties comprised $6,239 and $2,669 as of December 31, 2023 and December 31, 2022, respectively) | 108,347 | 105,733 | ||
Current portion of notes payable, net of debt issuance costs | 1,157,318 | 6,444 | ||
Current portion of finance lease liabilities | 3,196 | 1,686 | ||
Current portions due to sellers | 48,221 | 46,016 | ||
Current portion of operating lease liabilities | 22,750 | 24,068 | ||
Other current liabilities | 75,594 | 24,491 | ||
Total current liabilities | 1,415,426 | 208,438 | ||
Notes payable, net of debt issuance costs | 0 | 997,806 | ||
Long-term portion of operating lease liabilities | 124,329 | 166,347 | ||
Warrant liabilities | 0 | 7,373 | ||
Long-term portion of finance lease liabilities | 7,044 | 3,364 | ||
Due to sellers, net of current portion | 0 | 15,714 | ||
Long-term portion of contingent consideration | 0 | 2,800 | ||
Other liabilities | 1,941 | 32,810 | ||
Total liabilities | 1,548,740 | 1,434,652 | ||
Stockholders’ (Deficit) Equity: | ||||
Additional paid-in capital | 532,424 | 538,614 | ||
Accumulated deficit | (880,450) | (286,032) | ||
Total Stockholders' (Deficit) Equity before non-controlling interests | (347,973) | 252,631 | ||
Non-controlling interests | (187,028) | 241,644 | ||
Total Stockholders' (Deficit) Equity | (535,001) | 494,275 | ||
Total Liabilities and Stockholders' (Deficit) Equity | 1,013,739 | 1,928,927 | ||
Other | 13,099 | 19,203 | ||
Class A common stock | ||||
Stockholders’ (Deficit) Equity: | ||||
Common stock | [1] | 35 | 22 | |
Class B common stock | ||||
Stockholders’ (Deficit) Equity: | ||||
Common stock | [1] | $ 18 | $ 27 | |
|